The long half-life of tirzepatide means one day of delay won't cause a sudden loss of appetite control
Typically we administer one shot per week unless you are deficient in B12 and may require more
(The Washington Post notes that some Part D plans do cover Wegovy if prescribed for reducing cardiovascular risk, or Zepbound for obstructive sleep apnea, but not for obesity ( [38] ) ( [39] ).) In summary, nearly all current GLP-1 weight-loss usage depends on commercial/employer coverage , which is highly variable and restrictive
Delays longer than three days may require dose adjustment or schedule reset, and your provider needs to assess your individual situation before you inject
A poll by Leger Healthcare found 8 per cent of adults surveyed are taking a GLP-1 medication such as Ozempic or Mounjaro
The FDA eventually approved a number of GLP-1s for weight loss, including Saxenda, Wegovy, and Zepbound